-
Je něco špatně v tomto záznamu ?
MiR-15a-5p accelerated vascular smooth muscle cells viabilities and migratory abilities via targeting Bcl-2
H. Peng, J. Wang, S. Li
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
PubMed Central
od 2020
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- apoptóza MeSH
- matrixová metaloproteinasa 9 MeSH
- mikro RNA * genetika metabolismus MeSH
- myocyty hladké svaloviny metabolismus MeSH
- proliferace buněk MeSH
- svaly hladké cévní * metabolismus MeSH
- Publikační typ
- časopisecké články MeSH
Aortic dissection (AD) caused by the tear in the aortic wall threatens aorta, causing severe chest pain, syncope and even death. Fortunately, development of genetic technology provides promising approaches for AD treatment. To analyze impacts of miR-15a-5p on modulating cell viability and migratory ability of vascular smooth muscle cells (VSMCs). Ang II (0, 0.05 and 0.1 microM) treatment were applied for inducing inflammatory reactions of VSMCs. RNA expressions of miR-15a-5p with Bcl-2 was examined using RT-qPCR. CCK-8 and transwell evaluated cell viability and migratory ability, respectively. The binding about miR-15a-5p with Bcl-2 were detected by luciferase reporter assay. Western blot detected protein expressions of Bcl-2, MCP-1 and MMP-9. Ang II treatment not only accelerated VSMCs viability and migratory abilities, but also upregulated MCP-1 and MMP-9 protein expressions. MiR-15a-5p was detected to be promoted by Ang II. However, miR-15a-5p inhibitor decreased VSMC cell viability and migratory ability and suppressed protein expressions of MCP-1 and MMP-9. Bcl-2 was targeted and downregulated by miR-15a-5p. Nevertheless, high VSMC cell viability and migration caused by miR-15a-5p overexpression were hindered with overexpressed Bcl-2. MiR-15a-5p mimics also elevated MCP-1 and MMP-9 protein expressions, which were inhibited by Bcl-2 upregulation.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22029556
- 003
- CZ-PrNML
- 005
- 20230518102509.0
- 007
- ta
- 008
- 230113s2022 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934914 $2 doi
- 035 __
- $a (PubMed)36047726
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Peng, Hui $u Department of Cardiac Surgery, Xingtai People's Hospital, Xingtai, China
- 245 10
- $a MiR-15a-5p accelerated vascular smooth muscle cells viabilities and migratory abilities via targeting Bcl-2 / $c H. Peng, J. Wang, S. Li
- 520 9_
- $a Aortic dissection (AD) caused by the tear in the aortic wall threatens aorta, causing severe chest pain, syncope and even death. Fortunately, development of genetic technology provides promising approaches for AD treatment. To analyze impacts of miR-15a-5p on modulating cell viability and migratory ability of vascular smooth muscle cells (VSMCs). Ang II (0, 0.05 and 0.1 microM) treatment were applied for inducing inflammatory reactions of VSMCs. RNA expressions of miR-15a-5p with Bcl-2 was examined using RT-qPCR. CCK-8 and transwell evaluated cell viability and migratory ability, respectively. The binding about miR-15a-5p with Bcl-2 were detected by luciferase reporter assay. Western blot detected protein expressions of Bcl-2, MCP-1 and MMP-9. Ang II treatment not only accelerated VSMCs viability and migratory abilities, but also upregulated MCP-1 and MMP-9 protein expressions. MiR-15a-5p was detected to be promoted by Ang II. However, miR-15a-5p inhibitor decreased VSMC cell viability and migratory ability and suppressed protein expressions of MCP-1 and MMP-9. Bcl-2 was targeted and downregulated by miR-15a-5p. Nevertheless, high VSMC cell viability and migration caused by miR-15a-5p overexpression were hindered with overexpressed Bcl-2. MiR-15a-5p mimics also elevated MCP-1 and MMP-9 protein expressions, which were inhibited by Bcl-2 upregulation.
- 650 12
- $a svaly hladké cévní $x metabolismus $7 D009131
- 650 _2
- $a matrixová metaloproteinasa 9 $7 D020780
- 650 12
- $a mikro RNA $x genetika $x metabolismus $7 D035683
- 650 _2
- $a apoptóza $7 D017209
- 650 _2
- $a myocyty hladké svaloviny $x metabolismus $7 D032389
- 650 _2
- $a proliferace buněk $7 D049109
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Wang, Jianhua $u Department of Cardiac Surgery, Xingtai People's Hospital, Xingtai, China
- 700 1_
- $a Li, Shaohui $u Department of Cardiac Surgery, Xingtai People's Hospital, Xingtai, China
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, č. 5 (2022), s. 667-675
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36047726 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20230113 $b ABA008
- 991 __
- $a 20230518102503 $b ABA008
- 999 __
- $a ok $b bmc $g 1894751 $s 1180881
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 71 $c 5 $d 667-675 $e 20220831 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK198 $a Pubmed-20230113